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Epilepsy affects not only the patient but also the patient’s cohabiting relatives, to various degrees. This study investigated state
and trait anxiety, depression, and social fear and avoidance levels in 48 adult patients with epilepsy and 48 family members,
compared with 43 healthy control subjects, using the Beck Anxiety Inventory, the Beck Depression Inventory, the State-Trait
Anxiety Inventory, and the Liebowitz Social Anxiety Scale. The results suggested that the patients and their first-degree
relatives had higher levels of depression, state and trait anxiety, and avoidance compared with healthy subjects. The mothers
of patients with epilepsy had the highest level of depression and anxiety.
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Epilepsy is a chronic neurological disease characterized by
recurrent, unprovoked seizures. Epilepsy ranks as the sec-
ond most common complaint in neurology clinics, after
headaches. The prevalence of active epilepsy varies between
4 and 10 per 1,000. Although the prevalence of lifelong ep-
ilepsy is 5.8 per 1,000 in developed countries, it is 10.3 per
1,000 in urban populations of developing countries.1
Patients may frequently experience impairment in quality
of life and in social, vocational, and family relationships, and
psychiatric comorbidities may appear over the course of
epilepsy. Epidemiological studies reported psychiatric
comorbidities at a rate of 19%271% in patients with
epilepsy.2–4 The most prevalent psychiatric comorbidities in
epilepsy are mood disorders (24%274%), with depression
constituting 30% of these disorders, followed by anxiety
disorders (10%225%), psychosis (2%27%), and personality
disorders (1%22%).5
Epilepsy affects not only the patient but also the patient’s
cohabiting relatives, to various degrees. Families of children
who are diagnosed with epilepsy report having high stress,
and mothers of patients with epilepsy report depression and
impaired family functions at a high rate.6,7 Past research
demonstrated high levels of anxiety in parents of children
with uncontrolled seizures and comorbid disability that
causes inadequacy; in addition, themothers of these children
have a high rate of state anxiety. This leads to impairment in
family relationships and lifestyle.8–10 However, to our
knowledge, there are no similar studies conducted with
adult patients.
Diagnosing and treating social anxiety disorders is
important because these disorders may result in social
disability, loss of self-respect, phobic avoidance, impaired
lifestyle, fear of experiencing a seizure in public, and social
stigmatization. In this study, our goal was to determine the
respondents’ level of state and trait anxiety and social anx-
iety by using the Liebowitz Social Anxiety Scale with adult
patients with epilepsy and their cohabiting relatives (e.g.,
mother, father, spouse, sister, or brother). We also examined
whether epileptic seizures affected the social lives of
patients and their cohabitants.
METHODS
Participants
This prospective study, which was carried out from June to
December 2013, was approved by the Baskent University
Institutional Review Board (project number KA 13/114) and
was supported by the Baskent University Research Fund.
The study included 48 adult patients with epilepsywhowere
admitted to the neurology clinic of Baskent University, their
48 cohabiting relatives, as well as 43 healthy control
subjects.
All of the patients gave written informed consent. Parents
signed the consent form for patients ,18 years old. Exclu-
sion criteria included schizophrenia, schizophreniform dis-
order, bipolar affective disorder, mental retardation, other
neurological disorders, age,15 years, a history of any serious
and progressive organic disease, and, for women, being preg-
nant or breastfeeding.
All 48 patients with epilepsy (15–56 years old) were ex-
amined by a neurologist. The patients responded to ques-
tions about their age, gender, educational level, personal and
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family medical history, duration of epilepsy, age at the onset
of epilepsy, frequency of seizures, and drug usage. The dif-
ferential diagnosis was made via EEG, MRI, and neurologi-
cal examination. The frequency of seizures was classified as
very frequent (every day to 7 days), frequent (7–30 days),
rare (31 days to 1 year), or very rare (,1 per year). The types
of epileptic seizures were categorized as follows: primary
generalized epilepsy (generalized tonic-clonic, myoclonic and
absence) and focal epilepsy (focal motor seizures, complex
partial and secondary generalized).
After the neurological evaluation, a psychiatrist examined
the patients and questioned them about their social support
and feelings about the disease. The psychiatrist also evalu-
ated any of the patients’ stressful life events experienced
over the past 6 months in detail via semistructured inter-
views. Stressful life events included business, education, fi-
nance, health, grief, and migration, and legal, familial, social,
and marital problems. Psychiatric comorbidities were di-
agnosed using the Structured Clinical Interview for DSM-
IV. We explained the self-report measures to the patients
before they completed the questionnaires.
Measures
In this study, theBeckAnxiety Inventory, the BeckDepression
Inventory, the State-Trait Anxiety Inventory (STAI)-I, and the
STAI-II were completed by the patients, their cohabiting
relatives, and the control group. The Liebowitz Social Anxiety
Scale was completed by an interviewer.
The Turkish version of the Beck Depression Inventory
was used to assess the prevalence and severity of depressive
symptoms.11 The Beck Depression Inventory is a self-report
inventory created by Aaron Beck; it consists of 21 items that
respondents rank from 0 to 3. The total possible score ranges
from 0 to 63. A score of 0–13 indicates none/minimal de-
pression, whereas scores of 14–19, 20–28, and 29–63 indicate
mild, moderate, and severe depression, respectively. Indi-
viduals with a Beck Depression Inventory score $14 are
usually categorized as depressed. A reliability and validity
study of the Turkish version of the Beck Depression In-
ventory suggested that a score $17 should be used as an
indicator of major depression in the Turkish population.12
The Beck Anxiety Inventory is a 21-item scale that is
widely used to measure the severity of anxiety.13 Acceptable
validity and reliability have been reported in various pop-
ulations. We used the Turkish version of the Beck Anx-
iety Inventory, which is validated for use in the Turkish
population.14 Like the original Beck Anxiety Inventory, in
the Turkish version, each item is scored from 0 to 3, with 3
representing the most severe anxiety. A total score of 0–7 is
interpreted as none/minimal level of anxiety, whereas scores
of 8–15, 16–25, and 26–63 are interpreted as mild, moderate,
and severe anxiety, respectively. The scores for each of these
21 items were summed at the end of the psychological
evaluation.
The STAI-I and STAT-II are paper-and-pencil ques-
tionnaires that can be performed with individuals$14 years
old who can understand what they read.15 The STAI-I
determines how anxious a person feels at a certain time or
under certain conditions, whereas the STAI-II targets how
a person generally feels, independent of the patient’s current
condition. We used a validated and reliable Turkish version
of the inventory.16,17 A total score obtained from each scale
varies between 20 and 80. During the comparison, the
highest score indicates the highest level of anxiety.
The Liebowitz Social Anxiety Scale was developed by
Liebowitz in 1983. The measure is administered by the in-
terviewer to determine levels of fear/anxiety and avoidance
in the patient with social anxiety disorder in social interplay
and performance conditions. The measure comprises 24
items, including 13 performance scenarios and 11 social in-
terplay scenarios. The original and Turkish versions of the
scale are valid and reliable, and a cutoff score is not dis-
counted in the Turkish version.18,19 In this study, total scores
for each fear/anxiety and avoidance scenario are compared
statistically.
Sample Size Estimation
The Win Epi 2.0 program was used for sample size estima-
tion. Our calculations indicated that 30 subjects for each
groupwould allow 95% confidence intervals and 80% power.
Statistical Methods
SPSS 17.0 software (SPSS Inc., Chicago, IL) was used for the
statistical analysis of the data. Categorical measurements
were summarized as numbers and percentages, whereas
continuous measurements were summarized as means and
standard deviations (or medians and minimums to max-
imums where necessary). Chi-square or Fisher test statistics
were used to compare categorical variables. For the com-
parison of continuous measurements between groups, dis-
tributions were controlled for normality according to the
number of variables. One-way analysis of variance was used
for the parameters that showed a normal distribution, and
the Kruskal-Wallis test was used for parameters that did not
show a normal distribution. Post hoc analyses were planned
for significant results. The Kolmogorov-Smirnov test was
used for checking normality of the data distribution. For all
analyses, the level of statistical significance was p,0.05.
RESULTS
Sociodemographic Variables
The study comprised 139 subjects, including 48 patients with
epilepsy, 48 first-degree relatives, and 43 healthy control
subjects. The mean age was 27.4669.28 years (range, 15–56
years) for the patients with epilepsy, 39.4869.87 years
(range, 20–70 years) for their cohabiting relatives, and
38.28610.9 years (range, 19–65 years) for healthy control
subjects. There was a statistically significant difference be-
tween the patients and controls as well as between the
patients and relatives in terms of age. The age of the relatives
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and controls was similar. The three groups
were similar in terms of gender distribution.
Twenty-three of the relatives surveyed
were the parents of the patient. Aside from
these relatives, three others were brothers or
sisters of the patients and 22 were partners of
the patients. Marital status and educational
level were significantly different among
patients, relatives, and control subjects.
Consanguinity was present in 14 patients
(29.2%). Sociodemographic characteristics of
all groups (univariate analyses) are shown in
Table 1.
Clinical Characteristics
Epileptic findings. The neurological exami-
nation revealed normal findings in 42 pa-
tients. By contrast, two patients had postural
tremors in their hands, and one patient had
decreased hearing. In addition, one patient
had mild left hemiparesis, and another had
bilateral hip dysplasia. One patient had natal
sequela in the left arm.
MRI revealed normal findings in 40
patients. The pathological findings on MRI
included right mesial temporal sclerosis, bi-
lateral mesial temporal sclerosis, hydrocephalus, right
frontotemporal encephalomalacia, right temporoparietal
encephalomalacia, right temporal encephalitis, bilateral ce-
rebral cortical tubers, and right frontal cortical dysplasia,
each of which was found in one unique patient.
EEG demonstrated normal findings in 15 patients,
whereas 20 patients had diffuse epileptic discharges, nine
patients had epileptic activity in the right hemispheric areas,
and four patients had epileptic activity in the left hemi-
spheric areas.
The mean age at the onset of epilepsy was 17.15 years
(range, 1–54 years), and the mean examination age was 26.6
years (range, 1–55 years). Of the patients with epilepsy,
60.4% had focal epilepsy and 39.6% had primary generalized
epilepsy. Patients reported the following seizure frequen-
cies: very frequent, 12.8% (every day to 7 days); frequent,
10.6% (7–30 days); rare, 36.2% (31 days to 1 year); and very
rare, 40.4% (,1 per year).
Although 97.9% of the patients were receiving epileptic
drug therapy (e.g., valproic acid, 35.4%; levetiracetam, 22.9%;
carbamazepine, 45.8%; lamotrigine, 10.4%; and topiramate,
8.3%), one of the patients was not receiving any drug ther-
apy. The ratio of patients taking two antiepileptic drugs in
combination was 20.8%, whereas the ratio of patients tak-
ing three antiepileptic drugs in combination was 2.1%. The
remaining patients (77.1%) were taking only one antiepileptic
drug (Table 2).
The duration of disease in patients with epilepsy was ,1
year in 17%, 1–3 years in 14.9%, and.3 years in 68.1%. There
was a significant correlation between the duration of
epilepsy and scores on the STAI-I, the STAI-II, and the Beck
Depression Inventory (p,0.05). The patient who had the
longest duration of disease had the highest scores. However,
there was no significant relationship between the type of
epileptic seizure and the scores on the psychiatric scales
(Table 3).
Psychiatric findings. How patients described the disease was
categorized as follows: disease (70.8%), mental disorder (2.1%),
a burden for the family (41.6%), anxiety/worthlessness
(14.6%), and all of the above (6.2%). How patients felt about
themselves was categorized as follows: abnormal (4.2%),
different (31.2%), ill (25%), ashamed (10.4%), worried (35.4%),
a danger to oneself (22.9%), and a danger to others (35.4%). Of
the patients, 60.4% had experienced stressful life events in
the last 6 months, and 97.9% reported having social support
(Table 2).
All three groups showed statistically significant differ-
ences in their scores on the STAI-II, the Beck Anxiety In-
ventory, the Beck Depression Inventory, and the Liebowitz
Social Anxiety Scale fear/anxiety and avoidance subscales.
Paired comparisons between the patients and their relatives
revealed no differences in the scores. However, paired
comparisons between patients and controls and between
relatives and controls demonstrated statistical differences in
scores on all of the scales (Table 4).
The mothers of patients with epilepsy had the highest
scores on most of the scales. However, the Liebowitz Social
Anxiety Scale fear/anxiety and avoidance subscale scores
were similar in sisters/brothers and mothers. In addition,
TABLE 1. Comparison of the Groups by Sociodemographic Characteristicsa
Characteristic Group 1 Group 2 Group 3 Total p Value
Gender 0.89
Male 17 (35.4) 18 (37.5) 14 (32.6) 49 (35.3)
Female 31 (64.6) 30 (62.5) 29 (67.4) 90 (64.7)
Education, years 0.00
#8 14 (29.2) 31 (64.6) 9 (20.9) 54 (38.8)
9–11 17 (35.4) 8 (16.7) 18 (41.9) 43 (30.9)
.11 17 (35.4) 9 (18.8) 16 (37.2) 42 (30.2)
Employment status 0.00
Housewife 17 (35.4) 25 (52.1) 10 (23.3) 52 (37.4)
Employed 10 (20.8) 14 (29.2) 18 (41.9) 42 (30.2)
Retired 2 (4.2) 3 (6.3) 4 (9.3) 9 (6.5)
Student 17 (35.4) 0 (0.0) 4 (9.3) 21 (15.1)
Clerical 2 (4.2) 6 (12.5) 7 (16.3) 15 (10.8)
Marital status 0.00
Single 25 (52.1) 2 (4.2) 6 (14.0) 33 (23.7)
Married 23 (47.9) 46 (95.8) 35 (81.4) 104 (74.8)
Divorced 0 (0.0) 0 (0.0) 2 (4.7) 2 (1.4)
Cigarette use 0.00
Smoker 8 (16.7) 0 (0.0) 0 (0.0) 8 (5.8)
Nonsmoker 40 (83.3) 48 (100.0) 43 (100.0) 131 (94.2)
Trauma history 18 (37.5) 0 (0.0) 0 (0.0) 18 (12.9) 0.00
a Data are presented as N (%).The chi-square test was used to compare categorical variables. The
Kruskal-Wallis test was used to calculate p values. Group 1 comprises patients with epilepsy,
group 2 includes first-degree relatives of patients with epilepsy, and group 3 comprises healthy
control subjects.
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scores on the scales were mostly similar in the partners and
fathers (Table 5).
DISCUSSION
To our knowledge, this study is the first that compares social
anxiety and state and trait anxiety among adult patients with
epilepsy and their first-degree relatives. Our study suggested
that patients and their first-degree relatives had higher levels
of depression, state and trait anxiety, and avoidance compared
with healthy control subjects. Second, our results suggested
that the types of epileptic seizures were not associated with
the level of anxiety or depression in our patients or in their
relatives. Third, we found that the mothers of patients with
epilepsy had the highest level of depression and anxiety.
Depressive disorder, together with anxiety disorder, is
the most common psychiatric comorbidity in patients with
epilepsy.5,20–22 Studies have reported that the prevalence of
anxiety disorders is 14.8%225% in patients with epilepsy.23–25
Other psychiatric comorbidities and their prevalence rates are
as follows: generalized anxiety disorder (3%212%), panic
disorder (5%221%), social anxiety disorder (3%27%), post-
traumatic stress disorder (1%), and obsessive-compulsive
disorder (1%25%).25–27
Epileptic seizures affect not only the patient but also all
members of the patient’s family. The available studies fo-
cused on assessing the level of depression and anxiety in
children with epilepsy and in their mothers. These studies
found depression and anxiety levels to be higher in mothers
of children with epilepsy compared with mothers of healthy
children.8–10,28 We studied patients and their relatives who
had different levels of consanguinity and found that mothers
had the highest scores on most of the scales, as mentioned in
the above study. Because of the absence of similar studies, we
cannot compare all of our results with existing studies in the
literature. We performed this study because of a lack of
similar studies in adult patients. We determined that social
anxiety, depression, and state and trait anxiety levels were
higher in patients with epilepsy and in their family members
compared with a control group of healthy individuals.
Various factorsmay play a role in the development of anxiety
disorders and in the activity of neurotransmitter pathways in
patients with epilepsy. These factors may include age at the
onset of epilepsy, type of epilepsy (mostly focal and temporal
lobe), frequency of seizures, interictal or ictal EEG disorders,
side effects related to drugs used for treatment, surgery for
treatment, psychiatric comorbidities, disease-related social and
vocational problems and stigmatization, decrease in self-respect,
extremely protective behavior from the family, and conditioning
from experiences with unexpected seizures in the past.5
Fear and anxiety are the basic charac-
teristics of anxiety disorders. The feeling
of fear may be modulated by the frontal
cortex and the orbitofrontal cortex, which
are the key areas of the prefrontal cortex
that regulate feelings and reciprocal cir-
cuits shared by the amygdala. The cortico-
striatal-thalamic-cortical cycle may play
an important role in the response to anxi-
ety. Moreover, GABA-A, norepinephrine,
serotonin, and dopamine neurotransmitters
also play a role in both epilepsy and anxiety
disorders.29–31
TABLE 2. Clinical Features of Patients With Epilepsya
Characteristic Value
Epilepsy onset age in years 48 (17.1611.5)
Examination age in years 48 (26.669.6)
Consanguinity between mother and father 14 (29.2)
Stressful life events 29 (60.4)
Social support 47 (97.9)
Seizure frequency
Very frequent (every day out of 7 days) 6 (12.8)
Frequent (7 of 30 days) 5 (10.6)
Rare (31 days out of 1 year) 17 (36.2)
Very rare (less than once per year) 19 (40.4)
Epileptic seizure type
Primary generalized epilepsy 19 (39.6)
Focal epilepsy 29 (60.4)
Epileptic drug type
Not taking any drug 1 (2.1)
Valproic acid 17 (35.4)
Levetiracetam 11 (22.9)
Carbamazepine 22 (45.8)
Lamotrigine 5 (10.4)
Topiramate 4 (8.3)
How would you describe epilepsy?
Disease 34 (70.8)
Mental disorder 1 (2.1)
Burden for the family 20 (41.6)
Worthlessness 7 (14.6)
All of the above 3 (6.2)
How do the seizures make you feel?
Abnormal 2 (4.2)
Different 15 (31.2)
Sick 12 (25.0)
Ashamed 5 (10.4)
Worried 17 (35.4)
Insecure to himself/herself 11 (22.9)
Insecure to others 17 (35.4)
None 7 (14.6)
a Data are presented the mean 6 standard deviation or N (%). The chi-square
test was used to compare categorical variables.
TABLE 3. Comparisons of Scale Scores Between Seizure Typesa
Scale Generalized Epilepsy Focal Epilepsy Total p Value
LSAS
Anxiety subscale 51 (26–77) 53 (26–812) 51 (26–81) 0.94
Avoidance subscale 51 (26–84) 51 (26–80) 51 (26–84) 0.95
BAI 19 (5–45) 18 (1–44) 18 (1–45) 0.75
BDI 11 (4–27) 14.5 (3–35) 13 (3–35) 0.14
STAI-I 39 (25–55) 46 (21–76) 41 (21–76) 0.24
STAI-II 49 (35–56) 49 (23–71) 49 (23–71) 0.63
a Data are presented as the median (minimum–maximum). The Kruskal-Wallis test was used to
calculate p values. BAI, Beck Anxiety Inventory; BDI, Beck Depression Inventory; LSAS, Liebowitz
Social Anxiety Scale; STAI, State-Trait Anxiety Inventory.
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Social anxiety disorder is defined as the fear of social
conditions that involve interaction with other people, fear of
being insulted, or fear of feeling ashamed or foolish.
According to DSM-IV, the individual feels fear of showing
prominent anxiety signs and physiological signs of anxiety.
These signsmay be limited to a few occasions, such as eating,
writing, or making speeches in public, or they may be
common, occurring in many social situations.18 Generally,
social anxiety disorder appears between the ages of 13 and 24
years in single women andmay cause serious disturbances in
vocational, social, and academic performance. Psychodynamic,
conditioned, and cognitive models, as well as personality dis-
orders and genetic and biological factors, play a role in the
etiology. In the available studies, the prevalence of social anx-
iety disorders in patientswith epilepsywas 3%27%.25,26 In this
study, we found that both anxiety/fear and avoidance subscale
scores from the Liebowitz Social Anxiety Scale were higher in
patients with epilepsy and their relatives, particularly in the
patients’ mothers.
Anxiety and focal epileptic seizures have similar un-
derlying mechanisms. The amygdala and hippocampus play
major roles in both disorders.32 Among all types of epilepsy,
temporal lobe epilepsy is most frequently associated with
ictal fear.33 Edeh and Toone24 suggested that comorbid
anxiety is higher in temporal lobe epilepsy and focal non-
temporal lobe epilepsy, compared with generalized epilepsy.
Smith et al.34 found that how patients perceive seizures is
a more important predictor of anxiety. In our study, we
found that the type of epileptic seizure (general or focal) was
not associated with the psychological well-being of patients
or their first-degree relatives.
Our study had several limitations. For example, this
study’s cross-sectional design restricts our ability to make
inferences about causation. In addition, because the sample
was selected from a single center, our results may not be
generalizable to the population. Measuring constructs using
self-report scales may also be a limiting factor. In addition,
analyzing parents, siblings, and partners together may also
be a limitation to our study. Another possible limitation is
that we obtained patients’ history of epileptic seizures by
reviewing retrospective reports from the patients or their
families. We also did not evaluate stressful life events using
a standardized scale. Finally, particular drugs may be asso-
ciated with negative psychotropic effects, which may be
another limitation.
Unexpected seizures and fear of being damaged, feeling
anxiety from being ashamed as a result of losing control, con-
ditioning as a result of traumatic seizures developed previously,
and fear of stigmatization may cause both patients and their
cohabiting relatives to feel fear and avoid the community. Thus,
these patients and their cohabiting relatives could be reinte-
grated into society if these problems could be recognized and
treated. Our study showed that both patients with epilepsy and
their relatives have higher levels of anxiety compared with
healthy control subjects. We emphasize the importance and
necessity of recognizing and treating both groups to prevent
them from being excluded
from society. Apart from our
study, the studies in the liter-
ature have been applied only
in the mothers of patients
with epilepsy; therefore, fur-
ther studies in different
groups of relatives and in
more subjects would provide
more decisive information on
anxiety in patients with epi-
lepsy and their relatives.
TABLE 4. Comparisons of the Scale Scores Among Groupsa
Scale Group 1 Group 2 Group 3 Total p Value
p Values for Group Comparisons
Groups
1 and 2
Groups
1 and 3
Groups
2 and 3
BAI 18.5 (1–45) 14 (1–41) 7 (1–45) 13 (1–45) 0.00 0.14 0.00 0.00
BDI 13 (3–35) 12 (2–43) 7 (2–26) 11 (2–43) 0.00 0.55 0.00 0.002
STAI-I 41.5 (21–76) 37 (20–70) 33 (22–57) 37 (20–75) 0.00 0.84 0.05 0.09
STAI-II 49.5 (23–71) 44 (27–72) 39 (30–58) 44 (23–72) 0.00 0.34 0.00 0.002
LSAS
Anxiety subscale 51.5 (26–81) 48.5 (24–73) 34 (25–46) 41 (24–81) 0.11 0.48 0.00 0.00
Avoidance subscale 51.5 (26–84) 50.5 (24–76) 35 (24–46) 43 (24–84) 0.00 0.62 0.00 0.00
a Data are presented as the median (minimum–maximum). The Kruskal-Wallis test was used to calculate p values, except for the group comparisons, which
were calculated with the post hoc Mann-Whitney U test (p#0.02, Bonferroni correction). Group 1 comprises patients with epilepsy, group 2 includes first-
degree relatives of patients with epilepsy, and group 3 comprises healthy control subjects. BAI, Beck Anxiety Inventory; BDI, Beck Depression Inventory; LSAS,
Liebowitz Social Anxiety Scale; STAI, State-Trait Anxiety Inventory.
TABLE 5. Comparison of Scale Scores Among First-Degree Relativesa
Cohabiting Relative
LSAS
BAI BDI STAI-I STAI-IIAnxiety Avoidance
Mother 51.7612.1 50.7611.98 20.8611.9 18.3611.9 47613.8 51.2610.2
Father 35616.5 35616.5 13.3610.6 13.368.15 38.7618.5 45.3617.6
Partner 46.3612 47.9612.4 12.666.7 10.766.4 37.8612.5 42.667.3
Brother/sister 55.7617 57617.7 7.569.2 968.49 3363.46 41.3610.4
Total 48.4613 48.8613 15.9610.3 1469.79 41.5613.7 46.2610
a Data are presented as the mean 6 standard deviation. BAI, Beck Anxiety Inventory; BDI, Beck Depression Inventory;
LSAS, Liebowitz Social Anxiety Scale; STAI, State-Trait Anxiety Inventory.
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